Marek K - Search Results

1

[123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression.

Marek K, Innis R, van Dyck C, Fussell B, Early M, Eberly S, Oakes D, Seibyl J. Marek K, et al. Neurology. 2001 Dec 11;57(11):2089-94. doi: 10.1212/wnl.57.11.2089. Neurology. 2001. PMID: 11739831

2

Images in neuroscience. Neuroimaging, XII. SPECT imaging of dopamine nerve terminals.

Seibyl JP, Marek K, Innis RB. Seibyl JP, et al. Among authors: marek k. Am J Psychiatry. 1996 Sep;153(9):1131. doi: 10.1176/ajp.153.9.1131. Am J Psychiatry. 1996. PMID: 8780413 No abstract available.

3

Test/retest reproducibility of iodine-123-betaCIT SPECT brain measurement of dopamine transporters in Parkinson's patients.

Seibyl JP, Marek K, Sheff K, Baldwin RM, Zoghbi S, Zea-Ponce Y, Charney DS, van Dyck CH, Hoffer PB, Innis RB. Seibyl JP, et al. Among authors: marek k. J Nucl Med. 1997 Sep;38(9):1453-9. J Nucl Med. 1997. PMID: 9293807 Free article.

4

Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.

Seibyl JP, Marek K, Sheff K, Zoghbi S, Baldwin RM, Charney DS, van Dyck CH, Innis RB. Seibyl JP, et al. Among authors: marek k. J Nucl Med. 1998 Sep;39(9):1500-8. J Nucl Med. 1998. PMID: 9744331 Free article.

5

TechSight. Imaging. A molecular map for neurodegeneration.

Marek K, Seibyl J. Marek K, et al. Science. 2000 Jul 21;289(5478):409-11. doi: 10.1126/science.289.5478.409. Science. 2000. PMID: 10939953 No abstract available.

6

Hemi-parkinsonism due to a midbrain arteriovenous malformation: dopamine transporter imaging.

Goldstein S, Friedman JH, Innis R, Seibyl J, Marek K. Goldstein S, et al. Among authors: marek k. Mov Disord. 2001 Mar;16(2):350-3. doi: 10.1002/mds.1047. Mov Disord. 2001. PMID: 11295793 No abstract available.

7

Do dopamine agonists or levodopa modify Parkinson's disease progression?

Marek K, Jennings D, Seibyl J. Marek K, et al. Eur J Neurol. 2002 Nov;9 Suppl 3:15-22. doi: 10.1046/j.1468-1331.9.s3.2.x. Eur J Neurol. 2002. PMID: 12464117 Review.

8

(123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis.

Jennings DL, Seibyl JP, Oakes D, Eberly S, Murphy J, Marek K. Jennings DL, et al. Among authors: marek k. Arch Neurol. 2004 Aug;61(8):1224-9. doi: 10.1001/archneur.61.8.1224. Arch Neurol. 2004. PMID: 15313838

9

Neuroimaging trials of Parkinson's disease progression.

Seibyl J, Jennings D, Tabamo R, Marek K. Seibyl J, et al. Among authors: marek k. J Neurol. 2004 Oct;251 Suppl 7:vII9-13. doi: 10.1007/s00415-004-1704-5. J Neurol. 2004. PMID: 15505753 Review. No abstract available.

10

The role of radiotracer imaging in Parkinson disease.

Ravina B, Eidelberg D, Ahlskog JE, Albin RL, Brooks DJ, Carbon M, Dhawan V, Feigin A, Fahn S, Guttman M, Gwinn-Hardy K, McFarland H, Innis R, Katz RG, Kieburtz K, Kish SJ, Lange N, Langston JW, Marek K, Morin L, Moy C, Murphy D, Oertel WH, Oliver G, Palesch Y, Powers W, Seibyl J, Sethi KD, Shults CW, Sheehy P, Stoessl AJ, Holloway R. Ravina B, et al. Among authors: marek k. Neurology. 2005 Jan 25;64(2):208-15. doi: 10.1212/01.WNL.0000149403.14458.7F. Neurology. 2005. PMID: 15668415 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

453 results

Search Page

Filters